Stonebridge Capital Advisors’s Opko Health OPK Stock Holding History

Stonebridge Capital Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,000	Closed	-$3.2K	–	636
2023 Q3	$3.2K	Hold	2,000	–	–	﹤0.01%	758
2023 Q2	$4.34K	Hold	2,000	–	–	﹤0.01%	729
2023 Q1	$2.92K	Hold	2,000	–	–	﹤0.01%	766
2022 Q4	$2.5K	Hold	2,000	–	–	﹤0.01%	781
2022 Q3	$4K	Sell	2,000 -2,000	-50%	-$4.73K	﹤0.01%	713
2022 Q2	$10K	Hold	4,000	–	–	﹤0.01%	603
2022 Q1	$14K	Buy	+4,000	New	+$14.1K	﹤0.01%	609
2020 Q1	–	Sell	-500	Closed	-$1K	–	831
2019 Q4	$1K	Hold	500	–	–	﹤0.01%	804
2019 Q3	$1K	Hold	500	–	–	﹤0.01%	810
2019 Q2	$1K	Buy	+500	New	+$1.09K	﹤0.01%	854

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Stonebridge Capital Advisors's OPK Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Opko Health (OPK) in Q4 2023, closing a stake of 2,000 shares — an estimated $3.2K sold.

Stonebridge Capital Advisors first reported a position in OPK in Q2 2019 and held it in 10 quarters. The position peaked at $14K in Q1 2022. 218 funds tracked by Wall St. Rank hold OPK as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Opko Health position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 2,000 Opko Health shares in Q4 2023, an estimated $3.2K.
Stonebridge Capital Advisors first reported a position in Opko Health in Q2 2019 and held it in 10 quarters.
Stonebridge Capital Advisors's Opko Health position peaked at $14K in Q1 2022.
218 funds tracked by Wall St. Rank held Opko Health as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.